Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,476,248
  • Shares Outstanding, K 111,242
  • Annual Sales, $ 9,872 M
  • Annual Income, $ 871,000 K
  • EBIT $ 1,685 M
  • EBITDA $ 2,178 M
  • 60-Month Beta 0.62
  • Price/Sales 1.99
  • Price/Cash Flow 13.06
  • Price/Book 2.69

Options Overview Details

View History
  • Implied Volatility 20.33% (-0.18%)
  • Historical Volatility 17.04%
  • IV Percentile 26%
  • IV Rank 14.45%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 22) 5.53 (3.15%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 20
  • Volume Avg (30-Day) 534
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 8,405
  • Open Int (30-Day) 11,113
  • Expected Range 170.39 to 181.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.36
  • Number of Estimates 9
  • High Estimate 2.43
  • Low Estimate 2.32
  • Prior Year 2.23
  • Growth Rate Est. (year over year) +5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
174.48 +0.83%
on 12/23/25
193.35 -9.01%
on 11/25/25
-14.66 (-7.69%)
since 11/24/25
3-Month
174.33 +0.91%
on 10/31/25
197.55 -10.95%
on 10/21/25
-10.90 (-5.83%)
since 09/24/25
52-Week
148.70 +18.31%
on 01/16/25
197.55 -10.95%
on 10/21/25
+22.50 (+14.67%)
since 12/24/24

Most Recent Stories

More News
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 155.80 (+0.52%)
HSIC : 76.19 (-0.41%)
DGX : 175.92 (+0.48%)
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector?

Despite Bio-Techne’s weak performance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

TECH : 59.19 (-0.10%)
XLV : 155.80 (+0.52%)
DGX : 175.92 (+0.48%)
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

XLV : 155.80 (+0.52%)
DGX : 175.92 (+0.48%)
EXAS : 101.54 (-0.05%)
How Is Labcorp Holdings' Stock Performance Compared to Other Healthcare Stocks?

Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic about the stock’s prospects.

XLV : 155.80 (+0.52%)
DGX : 175.92 (+0.48%)
LH : 254.46 (+0.52%)
1 S&P 500 Stock to Target This Week and 2 We Brush Off

1 S&P 500 Stock to Target This Week and 2 We Brush Off

DGX : 175.92 (+0.48%)
STZ : 140.49 (+0.90%)
ISRG : 577.15 (-0.03%)
Engine Capital Issues Open Letter to the Trustees Controlling UniFirst Corporation

Calls on Carol Croatti, Matthew Croatti, Cynthia Croatti, and Cecelia Levenstein to Finally Meet with One of the Company’s Largest Independent Common Shareholders Emphasizes...

SEE : 41.36 (+0.27%)
DGX : 175.92 (+0.48%)
UNF : 199.57 (+0.29%)
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

DGX : 175.92 (+0.48%)
VTRS : 12.24 (+1.83%)
PFE : 25.03 (+0.60%)
UNH : 327.58 (+0.86%)
ADUS : 111.03 (+0.35%)
Quest Diagnostics Stock Outlook: Is Wall Street Bullish or Bearish?

Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

XHS : 108.29 (+0.32%)
DGX : 175.92 (+0.48%)
$SPX : 6,932.05 (+0.32%)
PIPR : 349.84 (+0.08%)
Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J. , Nov. 11, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash...

DGX : 175.92 (+0.48%)
Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference

SECAUCUS, N.J. , Nov. 3, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief...

DGX : 175.92 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 177.53
2nd Resistance Point 176.89
1st Resistance Point 176.41
Last Price 175.92
1st Support Level 175.28
2nd Support Level 174.64
3rd Support Level 174.15

See More

52-Week High 197.55
Fibonacci 61.8% 178.89
Last Price 175.92
Fibonacci 50% 173.13
Fibonacci 38.2% 167.36
52-Week Low 148.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar